MP
VMD icon

Mangrove Partners’s Viemed Healthcare VMD Stock Holding History

Mangrove Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Sell
76,179
-6,697
-8% -$66.3K 0.06% 137
2026
Q1 		$763K Buy
82,876
+10,933
+15% +$91K 0.06% 132
2025
Q4 		$535K Buy
+71,943
New +$493K 0.04% 154

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Mangrove Partners's VMD Position: Q2 2026 in Review

Mangrove Partners reduced its Viemed Healthcare (VMD) stake by 8.1% in Q2 2026, selling an estimated $66.3K and leaving 76,179 shares worth $868K. The position accounts for 0.06% of the portfolio, ranked #137.

Mangrove Partners first reported a position in VMD in Q4 2025 and has held it in 3 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Mangrove Partners held 76,179 shares of Viemed Healthcare worth $868K as of Q2 2026.
  • Mangrove Partners sold 6,697 Viemed Healthcare shares in Q2 2026, an estimated $66.3K.
  • Viemed Healthcare made up 0.06% of Mangrove Partners's portfolio in Q2 2026, its #137 holding.
  • Mangrove Partners first reported a position in Viemed Healthcare in Q4 2025 and has held it in 3 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.